The present invention relates to a pharmaceutical composition for treating renal diseases, containing dipyridamole as an active ingredient. More specifically, the present invention relates to a pharmaceutical use, for treating renal diseases, of dipyridamole, by inhibiting the proliferation of mesangial cells and decreasing the excretion of urinary albumin, wherein the dipyridamole is currently used as a treatment use for the support of anticoagulant agents so as to prevent angina and thromboembolism and for the prevention of a stroke.Linvention concerne une composition pharmaceutique pour traiter des maladies rénales, contenant du dipyridamole en tant quingrédient actif. Linvention concerne, plus spécifiquement, lutilisation pharmaceutique du dipyridamole pour le traitement des maladies rénales, par inhibition de la prolifération de cellules mésangiales et réduction de lexcrétion de lalbumine urinaire, le dipyridamole étant actuellement utilisé en tant que traitement pour le support dagents anticoagulants de façon à empêcher langine de poitrine et la thrombo-embolie et à prévenir un accident vasculaire cérébral.본 발명은 디피리다몰을 유효 성분으로 함유하는 신장 질환 치료용 의약 조성물에 관한 것이다. 더욱 상세하게는 현재 협심증, 혈전 색전증 예방을 위한 항응고제의 보조 및 뇌졸중 예방을 위한 치료 용도로 사용되고 있는 디피리다몰의 메산지움 세포의 증식 억제, 비뇨 알부민 배설 감소를 통한 신장 질환 치료용 의약 용도 발명에 관한 것이다.
